What is ICLUSIG:

(ICLUSIG is registered trademarks ARIAD PHARMACEUTICALS, INC.)

ICLUSIG is a medicine that contains the active substance Ponatinib and is available as tablets.

Iclusig – Ponatinib 15 mg, 30 mg and 45 mg is supplied for Tenders, Emergency imports, Orphan drug, Reference listed drugs, Comparator Drug, Name patient medicine and Innovator samples etc.

What is ICLUSIG used for?

ICLUSIG is indicated for the treatment of adult patients with T315I-positive chronic myeloid leukemia or T315I-positive Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).